Hanmi Financial Corporation
HAFC
Jodie situation report
Hanmi Financial Corporation's move is spreading beyond its market group.
No new filing conclusion is available. 21 of 27 group members are active now; 2 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- At least 18 of 27 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- ASB remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 9 of 27 members or fewer.
Who this business touches
The relationships behind HAFC
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
IRWDIronwood Pharmaceuticals, Inc.competitorFeb 26, 2026 ▾
“Hanmi Pharmaceutical is also developing a GLP-2 analog, to be administered once a month, and which is being evaluated in a Phase II clinical trial.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
HAFC is currently a Participant in the organic co-movement group Regional Banks. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.